KELLEY MAGUIRE: Open Payments
NPI 1710231857 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 49 payments from 5 companies in 2025. Trend: 2023 $195 · 2024 $468 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $381 |
| Boston Scientific Corporation | 19 | $250 |
| Collegium Pharmaceutical, Inc. | 11 | $190 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| PFIZER INC. | 1 | $17 |
Products named: QULIPTA, Belbuca, General - Pain Management, WaveWriter Alpha Prime 16, UBRELVY, Intracept, XTAMPZA, RELISTOR.
Industry payments across WA — which companies pay providers there.
